Global Rheumatology最新文献

筛选
英文 中文
Reumatología a la calle, la gran apuesta de PANLAR 2024 街头风湿病学,PANLAR 2024 的重大赌注
Global Rheumatology Pub Date : 2024-04-05 DOI: 10.46856/grp.233.e187
E. Fajardo
{"title":"Reumatología a la calle, la gran apuesta de PANLAR 2024","authors":"E. Fajardo","doi":"10.46856/grp.233.e187","DOIUrl":"https://doi.org/10.46856/grp.233.e187","url":null,"abstract":"Con el doctor Miguel Albanese, presidente de PANLAR, exploramos lo que Barranquilla tiene para sorprendernos. Reumatología a la calle es el legado que se busca dejar como muestra de la integración con la población.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"11 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140738710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANLAR 2024, Barranquilla brings an academic program for all interests PANLAR 2024,巴兰基亚为所有兴趣爱好者提供学术项目
Global Rheumatology Pub Date : 2024-04-05 DOI: 10.46856/grp.233.et188
Estefanía Fajardo
{"title":"PANLAR 2024, Barranquilla brings an academic program for all interests","authors":"Estefanía Fajardo","doi":"10.46856/grp.233.et188","DOIUrl":"https://doi.org/10.46856/grp.233.et188","url":null,"abstract":"Manuel Ugarte, president of the Scientific Committee of the PANLAR 2024 Congress, discusses the main topics of the event, as well as the integration with other specialties and patient groups. A program for all tastes, interests, and audiences.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"9 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140738523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANLAR 2024, Barranquilla traz um programa acadêmico para todos os interesses PANLAR 2024,巴兰基亚为所有兴趣爱好者提供学术计划
Global Rheumatology Pub Date : 2024-04-05 DOI: 10.46856/grp.233.ept188
Estefanía Fajardo
{"title":"PANLAR 2024, Barranquilla traz um programa acadêmico para todos os interesses","authors":"Estefanía Fajardo","doi":"10.46856/grp.233.ept188","DOIUrl":"https://doi.org/10.46856/grp.233.ept188","url":null,"abstract":"Manuel Ugarte, presidente do Comitê Científico do Congresso PANLAR 2024, fala sobre os principais temas do evento, bem como sobre a integração com outras especialidades e grupos de pacientes. Um programa para todos os gostos, interesses e públicos.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"28 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140740049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-Centered Medicine Takes Center Stage at PANLAR 2024 以患者为中心的医疗在 PANLAR 2024 展会上占据中心位置
Global Rheumatology Pub Date : 2024-04-01 DOI: 10.46856/grp.27.et184
Estefanía Fajardo
{"title":"Patient-Centered Medicine Takes Center Stage at PANLAR 2024","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.et184","DOIUrl":"https://doi.org/10.46856/grp.27.et184","url":null,"abstract":"This year, in addition to the VII Pan American Congress of Patients with Rheumatic Diseases, patients will have an active role in the development of PANLAR 2024 Congress within the scientific program and community activities.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"33 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140797146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diretrizes de Prática Clínica para Artrite Reumatoide da PANLAR: Uma Abordagem Abrangente para Todos PANLAR 类风湿关节炎临床实践指南:面向所有人的综合方法
Global Rheumatology Pub Date : 2024-04-01 DOI: 10.46856/grp.27.ept185
Estefanía Fajardo
{"title":"Diretrizes de Prática Clínica para Artrite Reumatoide da PANLAR: Uma Abordagem Abrangente para Todos","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.ept185","DOIUrl":"https://doi.org/10.46856/grp.27.ept185","url":null,"abstract":"Após 15 anos, a PANLAR atualizará as diretrizes para Artrite Reumatoide (AR) visando abordar as especificidades dos sistemas de saúde e o manejo da doença nos países membros. Além disso, espera que sejam amigáveis para diversos públicos estratégicos.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"124 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicina centrada en los pacientes, un rol protagónico en PANLAR 2024 以患者为中心的医疗,在 PANLAR 2024 中发挥主导作用
Global Rheumatology Pub Date : 2024-04-01 DOI: 10.46856/grp.27.e184
E. Fajardo
{"title":"Medicina centrada en los pacientes, un rol protagónico en PANLAR 2024","authors":"E. Fajardo","doi":"10.46856/grp.27.e184","DOIUrl":"https://doi.org/10.46856/grp.27.e184","url":null,"abstract":"Este año, adicional al VII Congreso Panamericano de Pacientes con Enfermedades Reumáticas, contarán con participación activa en el desarrollo del Congreso PANLAR 2024 en el marco del programa científico y actividades con la comunidad.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"413 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140757626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Rheumatology becomes the official journal of PANLAR 全球风湿病学》成为 PANLAR 的官方期刊
Global Rheumatology Pub Date : 2024-04-01 DOI: 10.46856/grp.27.et186
Estefanía Fajardo
{"title":"Global Rheumatology becomes the official journal of PANLAR","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.et186","DOIUrl":"https://doi.org/10.46856/grp.27.et186","url":null,"abstract":"Framed within the scientific dissemination in Rheumatology, GR will have a special participation in PANLAR 2024 with a narrative workshop. The commitment of the journal to maintain and strengthen standards of quality and excellence in the dissemination of scientific knowledge remains.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"371 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140773377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Rheumatology se convierte en la revista oficial de PANLAR 全球风湿病学》成为 PANLAR 的官方期刊
Global Rheumatology Pub Date : 2024-04-01 DOI: 10.46856/grp.27.e186
E. Fajardo
{"title":"Global Rheumatology se convierte en la revista oficial de PANLAR","authors":"E. Fajardo","doi":"10.46856/grp.27.e186","DOIUrl":"https://doi.org/10.46856/grp.27.e186","url":null,"abstract":"Enmarcada en la difusión científica en Reumatología, GR tendrá participación especial en PANLAR 2024 con un taller de narrativas. El compromiso de la revista con mantener y fortalecer los estándares de calidad y excelencia en la difusión del conocimiento científico se mantiene.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"56 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140775060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Practice Guidelines for Rheumatoid Arthritis PANLAR: A Comprehensive Approach for All 类风湿关节炎临床实践指南 PANLAR:面向所有人的综合方法
Global Rheumatology Pub Date : 2024-04-01 DOI: 10.46856/grp.27.et185
Estefanía Fajardo
{"title":"Clinical Practice Guidelines for Rheumatoid Arthritis PANLAR: A Comprehensive Approach for All","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.et185","DOIUrl":"https://doi.org/10.46856/grp.27.et185","url":null,"abstract":"After 15 years, PANLAR will update the Rheumatoid Arthritis (RA) guidelines, aiming to address the specificities of healthcare systems and disease management in its member countries. Additionally, it hopes to make them user-friendly for diverse strategic audiences.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"8 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Certolizumab pegol in severe rheumatoid arthritis: Real-world evidence in an Argentine cohort: Achievement of targets (T2T) at 3 months and predictive factors. 赛妥珠单抗 pegol 治疗严重类风湿关节炎:阿根廷队列中的现实世界证据:3 个月达标情况 (T2T) 和预测因素。
Global Rheumatology Pub Date : 2024-02-22 DOI: 10.46856/grp.10.et182
R. G. García Salinas, S. Magri, Álvaro Ruta
{"title":"Certolizumab pegol in severe rheumatoid arthritis: Real-world evidence in an Argentine cohort: Achievement of targets (T2T) at 3 months and predictive factors.","authors":"R. G. García Salinas, S. Magri, Álvaro Ruta","doi":"10.46856/grp.10.et182","DOIUrl":"https://doi.org/10.46856/grp.10.et182","url":null,"abstract":"Introduction: Certolizumab pegol (CTZ) is a tumor necrosis factor-alpha (TNF-α) inhibitor biological agent that has demonstrated efficacy in controlling rheumatoid arthritis (RA). Identifying predictive factors for treatment success and assessing its effectiveness in a real-world clinical setting are crucial for decision-making. Objective: To evaluate the response to CTZ in patients with RA in a real-world cohort, measuring the reduction in DAS 28, HAQ, frequency of remission, and low disease activity (LDA) at three months, identifying predictive factors, and evaluating the reduction in the use of corticosteroids. Methods: A prospective real-world observational study included patients over 18 years of age with RA (ACR/EULAR 2010 criteria) who initiated CTZ and were followed for three months. Demographic, clinical, comorbidity, treatment, and disease activity data were recorded. Results: Out of 2092 RA patients treated with CTZ between 2016 and 2021, 90% had a poor prognosis, and 60% had high disease activity. Among 1673 patients followed for three months, a reduction in DAS 28 (-1.9) and HAQ (-0.63) was observed. At three months, 10.5% achieved remission, and 40% achieved LDA. Predictive factors for remission included age (OR: 0.97) and DAS 28 (OR: 0.58); for LDA, age (OR: 0.97), DAS 28 (OR: 0.61), first-line CTZ (OR: 1.6), and HAQ (OR: 0.61). Additionally, there was a reduction in the use of glucocorticoids (-3.1 mg prednisone). Conclusions: CTZ is effective in RA, emphasizing patient selection and an early treatment approach. This study supports the efficacy of CTZ.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140439324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信